Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thiamine As An Adjuvant Therapy For Hyperlactatemia In Septic Shock Patients: A Prospective Randomized Study

NCT03649009 is registered in ClinicalTrials.gov with Universiti Kebangsaan Malaysia Medical Centre as lead sponsor.

NCT NCT03649009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03649009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thiamine As An Adjuvant Therapy For Hyperlactatemia In Septic Shock Patients: A Prospective Randomized Study
Lead sponsor
Universiti Kebangsaan Malaysia Medical Centre
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2018
Completion date
March 31, 2019
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlactatemia